Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06319560 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hydroxychloroquine in Type 2 Diabetes During Pregnancy

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 12, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: 6 to 5v5 Show 4 more changesShow less
    • Start date: Mar 1, 2024 to Mar 24, 2024
    • Secondary endpoints: 14 to 12
    • Study description shortened, about 23 words
    • Eligibility criteria expanded, about 5 words
  2. Start date: Jan 2, 2024 to Mar 1, 2024
    • Primary completion date: Jan 1, 2026 to Jun 1, 2026
    v4
  3. Secondary endpoints: details revised at 11 of 14 entriesv3
  4. Secondary endpoints revised (14)
    • Study description expanded, about 26 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to compare the use of hydroxychloroquine as an adjunct to the current treatment of pregnant women with Type 2 diabetes mellitus. The main questions it aims to answer are: * Does hydroxychloroquine improve the pregnancy outcomes in women with type 2 diabetes during pregnancy? * Does hydroxychloroquine improve the inflammatory markers in women with type 2 diabetes during pregnancy? Participants will be randomised into the intervention and control group. The control group will be on standard treatment where as the intervention group will receive hydroxychloroquine as an adjunct of standard treatment
Trial Details
NCT Number NCT06319560
Lead Sponsor National University of Malaysia
Conditions
(from sponsor)		 Diabetes in Pregnancy, Type 2 Diabetes
Related terms Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetes, Gestational
Enrollment 56 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov